Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pituitary Neoplasms × Supine Position × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Pure Autonomic Failure 1 Pituitary Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Hypotension 1 Abdominal Cancer 1

Interventions

Cabergoline 6 pasireotide 4 Surgical Procedures, Operative 4 Propofol 3 Dexmedetomidine 3 lanreotide 2 Temozolomide 2 Sevoflurane 2 Saline Solution 2 Rosiglitazone 2 Radiotherapy 2 Radiosurgery 2 Proton Therapy 2 Hydrocortisone 2 Dexamethasone 2 Desflurane 2 pegvisomant 1 parecoxib 1 lutetium Lu 177 dotatate 1 loxoprofen 1 entinostat 1 corticorelin ovine 1 Yoga 1 Trimethoprim 1 Transcranial Magnetic Stimulation 1 Tramadol 1 Thyrotropin-Releasing Hormone 1 TBR-760 1 Surveys and Questionnaires 1 Supine Position 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04584866 2025-04-29

PosESS

University Hospital, Basel, Switzerland

Phase NA Completed

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡